Watson Can't Skirt Shire's Colitis Drug Patent Suit

Law360, New York (March 25, 2013, 3:26 PM EDT) -- A Florida federal judge on Thursday declined to rule outright that Irish drugmaker Shire Development LLC’s patent for its ulcerative colitis drug Lialda was invalid, rejecting an attempt by Watson Pharmaceuticals Inc. to have the court clear the way for its generic version of the drug.

U.S. District Judge Donald M. Middlebrooks denied both Shire’s motion for summary judgment and Watson’s motion for summary judgment of noninfringement, saying there remain genuine issues of material fact as to whether Watson’s abbreviated new drug application for a generic...
To view the full article, register now.